While the human body manufactures an endogenous Testosterone level in the range of 70mg/week, the Testosterone dosage required for physique and performance enhancement must sit well above that, with a minimum being in the range of 300 – 500mg per week for beginners, for example. Intermediate and/or experienced anabolic steroid users can venture even higher than that. In addition to the higher bodybuilding dosage, the injections must be administered much more frequently. While TRT patients can ‘get by’ with a single 250mg injection of Testosterone Enanthate once per week (or even once every two weeks as is commonly applied clinically), an athlete or bodybuilder would have to administer 250mg of Testosterone Enanthate twice per week (for a total of 500mg) in order to experience a steady onset of performance and physique enhancing benefits. This is very necessary due to a constant steady peak blood plasma level of the anabolic steroid that is necessary for constant biological action within muscle tissue in the body. Testosterone Enanthate, as mentioned earlier in this article, exhibits a half-life of 7 – 10 days, but although its half-life is 7 – 10 days, sharp declines in blood plasma levels begin to occur several days before the end of the half-life period. When performance and physique enhancement is desired, the administration of doses must occur more frequently in order to keep blood plasma levels elevated as best as possible. For medical purposes such as TRT, sharp spikes and peaks and valleys in blood plasma levels can be afforded (although it is still not optimal), as the patient is simply utilizing Testosterone to obtain normal physiological levels, and is therefore not particularly concerned with dramatic performance or physique changes on a weekly basis.
There is limited information available on the pharmacokinetics of oxymetholone.  It appears to be well-absorbed with oral administration .  Oxymetholone has very low affinity for human serum sex hormone-binding globulin (SHBG), less than 5% of that of testosterone and less than 1% of that of DHT.  The drug is metabolized in the liver by oxidation at the C2 position, reduction at the C3 position, hydroxylation at the C17 position, and conjugation .   The C2 hydroxymethylene group of oxymetholone can be cleaved to form mestanolone (17α-methyl-DHT), which may contribute to the effects of oxymetholone.  The elimination half-life of oxymetholone is unknown.  Oxymetholone and its metabolites are eliminated in the urine .  
Oxymetholone (also known as anapolon or anadrol) is a very drastic synthetic steroid, 17-alpha-alkylated modification of dihydrotestosterone. It was developed for the treatment of osteoporosis and anaemia, as well as to stimulate muscle gain in malnourished and debilitated patients. Oxymetholone has been approved by the American Food and Drug Administration (FDA) for use in humans. Later there where created non-steroidal drugs that effectively could treat anaemia and osteoporosis; because of this anapolon lost his popularity and by 1993 Syntex decided to cease the production of the drug, as well as other manufacturers did.